Related Experiment Video
Updated: Dec 8, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Quantification of an Adverse Outcome Pathway Network by Bayesian Regression and Bayesian Network Modeling
S Jannicke Moe1, Raoul Wolf1, Li Xie1,2,3
1Norwegian Institute for Water Research (NIVA), Oslo, Norway.
This study introduces a novel, less data-intensive method for quantifying adverse outcome pathways (AOPs) using Bayesian networks and regression modeling. This approach enhances toxicological risk assessment by providing a flexible framework for predicting adverse outcomes from molecular initiating events.
Area of Science:
- Environmental Toxicology
- Computational Toxicology
- Risk Assessment
Background:
- The Adverse Outcome Pathway (AOP) framework systematically links mechanistic processes to toxicity endpoints.
- Implementation in risk assessments is hindered by a lack of quantitative AOP models (qAOPs) and uncertainty assessment.
- Existing qAOP models often rely on data-intensive systems biology approaches.
Purpose of the Study:
- To propose a less data-demanding approach for quantifying AOPs and AOP networks using regression modeling and Bayesian networks (BNs).
- To demonstrate the utility of this approach through a case study of AOP #245 involving pesticide exposure in Lemna minor.
- To develop a quantitative AOP-Bayesian Network (AOP-BN) model for predicting adverse outcomes.
Main Methods:
- Employed Bayesian regression modeling to quantify causal relationships within AOPs, including dose-response and key event relationships.
- Utilized fitted regression models with associated uncertainty to simulate response values.
- Parameterized Bayesian Network (BN) models using simulated values to create a quantitative AOP-BN.
Main Results:
- The developed AOP-BN model successfully reflected the network structure of AOP #245, encompassing molecular initiating events (MIEs), key events (KEs), and adverse outcomes (AO).
- The model demonstrated high accuracy in internal validation, particularly when run from intermediate nodes and when lower resolution for the AO was acceptable.
- Despite limitations due to a small dataset, the study proved the concept of combining Bayesian regression and BN modeling for AOP quantification.
Conclusions:
- The proposed approach offers a viable, less data-intensive alternative for quantifying AOPs and AOP networks.
- The AOP-BN model provides a flexible tool for prognostic, diagnostic, and omnidirectional inference within toxicological pathways.
- This proof-of-concept study paves the way for more robust quantitative risk assessments using AOPs.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Survival Tree
Building a Survival Tree
Constructing a...
Kaplan-Meier Approach
Biostatistics: Overview
Discrete variables are...
Causality in Epidemiology

